Company / SG&A per Share
Coherus Oncology, Inc. SG&A per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$2.01
FY2019
5-year range
$0.22 / $2.01
FY2015-FY2019
Trend
+27.5%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has increased for 4 consecutive years, from $0.22 in FY2015 to $2.01 in FY2019.
Based on SEC 10-K filings.
2.01 in FY2019 with a 5-year CAGR of +11.9%.
Increased from $1.56 to $2.01 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +64.6%
- 5-Year CAGR
- +11.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- Coherus Oncology, Inc.'s sg&a per share has grown for 4 consecutive years.
- In FY2019, sg&a per share increased 27.5% year-over-year.
- Lowest sg&a per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $2.01 | +27.5% |
| FY2018 | $1.57 | +1.1% |
| FY2017 | $1.56 | +245.7% |
| FY2016 | $0.45 | +100.6% |
| FY2015 | $0.22 | -80.4% |
| FY2014 | $1.14 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026